Clinically significant mutations in HIV-infected patients with lung adenocarcinoma Journal Article


Authors: Thaler, J.; Sigel, C.; Beasley, M. B.; Wisnivesky, J.; Crothers, K.; Bauml, J.; Hysell, K.; Emu, B.; Borsu, L.; Sigel, K.
Article Title: Clinically significant mutations in HIV-infected patients with lung adenocarcinoma
Abstract: BACKGROUND: Lung cancer is a major cause of death in HIV-infected (HIV+) persons. In this study, we compared the prevalence of tumour EGFR and KRAS mutations in a cohort of lung adenocarcinoma patients by HIV status. METHODS: We collected data from 55 HIV+ patients with lung adenocarcinoma matched to 136 uninfected comparators. We compared the prevalence of EGFR and KRAS mutations by HIV status. We then compared survival by HIV status and by cancer mutation status among HIV+ subjects. RESULTS: Presence of KRAS and EGFR genetic alterations did not vary by HIV status (all P>0.1). There was no difference in overall survival by HIV status or by mutation status among HIV+ subjects. CONCLUSIONS: We found no major differences in the prevalence of EGFR or KRAS lung adenocarcinoma mutations by HIV status, suggesting that mutational testing should be conducted similarly regardless of the HIV status.
Keywords: middle aged; survival rate; genetics; mutation; cancer staging; human immunodeficiency virus infection; follow up; follow-up studies; neoplasm staging; adenocarcinoma; cohort studies; lung neoplasms; epidermal growth factor receptor; cohort analysis; receptor, epidermal growth factor; pathology; tumor marker; virology; lung tumor; protein p21; proto-oncogene proteins p21(ras); hiv infections; egfr protein, human; kras protein, human; human immunodeficiency virus 1; hiv-1; humans; prognosis; human; male; female; biomarkers, tumor
Journal Title: British Journal of Cancer
Volume: 117
Issue: 9
ISSN: 0007-0920
Publisher: Nature Publishing Group  
Date Published: 2017-10-24
Start Page: 1392
End Page: 1395
Language: English
DOI: 10.1038/bjc.2017.333
PUBMED: 28934759
PROVIDER: scopus
PMCID: PMC5672933
DOI/URL:
Notes: Article -- Export Date: 4 December 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carlie Selbo Sigel
    115 Sigel